These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 32478439
1. A Series of Benzylidenes Linked to Hydrazine-1-carbothioamide as Tyrosinase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationship. Hosseinpoor H, Iraji A, Edraki N, Pirhadi S, Attarroshan M, Khoshneviszadeh M, Khoshneviszadeh M. Chem Biodivers; 2020 Aug; 17(8):e2000285. PubMed ID: 32478439 [Abstract] [Full Text] [Related]
2. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities. Iraji A, Khoshneviszadeh M, Bakhshizadeh P, Edraki N, Khoshneviszadeh M. Med Chem; 2020 Aug; 16(7):892-902. PubMed ID: 31339074 [Abstract] [Full Text] [Related]
3. Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers. Dehghani Z, Khoshneviszadeh M, Khoshneviszadeh M, Ranjbar S. Bioorg Med Chem; 2019 Jun 15; 27(12):2644-2651. PubMed ID: 31000406 [Abstract] [Full Text] [Related]
9. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors. Tang J, Liu J, Wu F. Bioorg Chem; 2016 Dec 01; 69():29-36. PubMed ID: 27669118 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of N-aryl-2-phenyl-hydrazinecarbothioamides: Experimental and theoretical analysis on tyrosinase inhibition and interaction with HSA. Sousa-Pereira D, Chaves OA, Dos Reis CM, de Oliveira MCC, Sant'Anna CMR, Netto-Ferreira JC, Echevarria A. Bioorg Chem; 2018 Dec 01; 81():79-87. PubMed ID: 30118988 [Abstract] [Full Text] [Related]
11. Evaluation of novel pyrimidine derivatives as a new class of mushroom tyrosinase inhibitor. Mirmortazavi SS, Farvandi M, Ghafouri H, Mohammadi A, Shourian M. Drug Des Devel Ther; 2019 Dec 01; 13():2169-2178. PubMed ID: 31371919 [Abstract] [Full Text] [Related]
12. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors. Radhakrishnan S, Shimmon R, Conn C, Baker A. Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4085-91. PubMed ID: 26318997 [Abstract] [Full Text] [Related]
17. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies. Bagherzadeh K, Shirgahi Talari F, Sharifi A, Ganjali MR, Saboury AA, Amanlou M. J Biomol Struct Dyn; 2015 Oct 01; 33(3):487-501. PubMed ID: 24601849 [Abstract] [Full Text] [Related]
18. Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors. Mahdavi M, Ashtari A, Khoshneviszadeh M, Ranjbar S, Dehghani A, Akbarzadeh T, Larijani B, Khoshneviszadeh M, Saeedi M. Chem Biodivers; 2018 Jul 01; 15(7):e1800120. PubMed ID: 29766648 [Abstract] [Full Text] [Related]
19. Design, synthesis of Cinnamyl-paeonol derivatives with 1, 3-Dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro. Tang K, Jiang Y, Zhang H, Huang W, Xie Y, Deng C, Xu H, Song X, Xu H. Bioorg Chem; 2021 Jan 01; 106():104512. PubMed ID: 33293056 [Abstract] [Full Text] [Related]